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Abstract
A variety of cellular pathways are regulated by protein modifications with ubiquitin-family
proteins. SUMO, the Small Ubiquitin-like MOdifier, is covalently attached to lysine on target
proteins via a cascade reaction catalyzed by E1, E2, and E3 enzymes. A major barrier to
understanding the diverse regulatory roles of SUMO has been a lack of suitable methods to
identify protein sumoylation sites. Here we developed a mass-spectrometry (MS) based
approach combining chemical and enzymatic modifications to identify sumoylation sites.
We applied this method to analyze the auto-sumoylation of the E1 enzyme in vitro and com-
pared it to the GG-remnant method using Smt3-I96R as a substrate. We further examined
the effect of smt3-I96Rmutation in vivo and performed a proteome-wide analysis of protein
sumoylation sites in Saccharomyces cerevisiae. To validate these findings, we confirmed
several sumoylation sites of Aos1 and Uba2 in vivo. Together, these results demonstrate
that our chemical and enzymatic method for identifying protein sumoylation sites provides a
useful tool and that a combination of methods allows a detailed analysis of protein sumoyla-
tion sites.
Introduction
SUMO is a member of the ubiquitin-like protein family, and like ubiquitin, is covalently
attached to target proteins via an isopeptide bond between the C-terminus of SUMO and the
amino group of lysine on the target protein [1,2]. The SMT3 gene encodes SUMO in Saccharo-
myces cerevisiae and the Smt3 protein is activated by the heterodimeric Aos1-Uba2 complex,
the SUMO E1 activating enzyme in S. cerevisiae [3]. Smt3 is then transferred to Ubc9, the sole
SUMO E2 conjugating enzyme [4]. The SUMO E3 ligases Siz1, Siz2 and Mms21 are believed to
control sumoylation of specific substrates in cells [5,6]. Like other post-translational modifica-
tions, protein sumoylation is reversible and two SUMO-specific isopeptidases, Ulp1 and Ulp2,
have been identified in S. cerevisiae [7,8]. While much is known about the identity and struc-
ture of the enzymes that catalyze reversible sumoylation [9], their regulation and substrate
selectivity in vivo are not well understood.
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A key feature of the enzymatic cascade that catalyzes the sequential transfer of ubiquitin
family proteins is that modular ubiquitin-fold domains often mediate specific protein-protein
interactions to regulate the specificity and efficiency of the transfer reaction [10–12]. Studies of
Ubc9 have shown that sumoylation of Ubc9 regulates its activity in S. cerevisiae and substrate
selectivity in humans [13–15]. Other enzymes in the SUMO pathways are also known to be
sumoylated, including the Aos1 and Uba2 subunits of the E1 enzyme, Siz1, Siz2, and the
Smc5-Smc6-Mms21 complex [6,16,17]. However, it has been unclear whether sumoylation of
these enzymes may regulate their activities and/or substrate specificity. Several studies have
investigated the role of auto-sumoylation of the E1 enzyme, suggesting that sumoylation of the
C terminus of SAE2, the human ortholog of Uba2, is required for its localization to the nuclear
periphery, and that sumoylation of the E1’s Cys domain affects the interaction between the E1
and E2 enzymes [18,19]. Despite these studies, further studies are needed to understand the
function of E1 and E3 sumoylation.
Hundreds of proteins are known to be sumoylated in S. cerevisiae [16,17,20–26], and the
specific sites at which they are modified have been identified in some cases [27–35]. One
approach for identifying sumoylation sites has been the use of a consensus sumoylation motif
to predict candidate sumoylation sites that are then evaluated by mutagenesis studies, i.e., the
ψKX(D/E) consensus motif, where ψ is a large hydrophobic residue and X is any amino acid
[27]. Biochemical studies have shown that this consensus motif interacts with the SUMO E2
enzyme Ubc9 [36–38]. This consensus motif has been successfully used in the analysis of pro-
teins in which relatively few candidate sumoylation sites are present [26,33,39–42]. However,
identifying sumoylation sites in large proteins, which can have many candidate sumoylation
sites based on this consensus motif alone, requires alternative methods. Moreover, functionally
relevant sumoylation sites that do not conform to the above consensus motif have been
reported, including K164 of Pol30/PCNA and K153 of Ubc9 [13,28]. A suitable and unbiased
method to identify protein sumoylation sites is therefore needed.
Identification of sumoylation sites by MS typically relies on endopeptidase digestion of a
sumoylated protein, then detection of a branched peptide with an intact SUMO remnant [27].
For example, trypsin digestion of Smt3 leaves a five amino acid remnant (EQIGG) on the lysine
of branched sumoylated peptides, which can be identified by tandemMS analysis [17,21,27].
In the case of mammalian SUMO-1, SUMO-2 and SUMO-3, the use of trypsin would yield a
remnant of 19, 19, and 32 amino acids, respectively. In general, as the length of the SUMO
remnant increases, the more likely it will fragment during tandemMS analysis to yield frag-
ment ions that are unaccounted for by database search methods, thus compromising the identi-
fication. One way to minimize this difficulty is to use alternative endopeptidases to reduce the
size of SUMO remnant and chemical modification to improve the sequencing [43,44]. Another
way is to create a mutant of SUMO with an arginine preceding the C-terminal Gly-Gly repeat
so that a relatively short SUMO remnant, i.e., Gly-Gly, remains attached to sumoylated pep-
tides following trypsin digestion [45], and this strategy has significantly improved the identifi-
cation of sumoylation sites in both S. cerevisiae and human cells [45–47]. For example, the use
of the smt3-I96Rmutant in S. cerevisiae facilitated the identification of 22 sumoylation sites
compared to 7 sumoylation sites using WT SMT3 [45]. However, extensive sequence coverage
of sumoylated proteins is often needed to ensure that most, if not all, of the sumoylation sites
are identified. The use of endopeptidases with cleavage specificity different from trypsin would
improve protein sequence coverage, but would then require a cumbersome re-engineering of
SUMO to create a shorter SUMO remnant for the use of each endopeptidase. A general strat-
egy to circumvent these difficulties associated with SUMO remnants is therefore desirable.
We previously reported a proteome-wide approach to identify and quantify sumoylated
proteins using quantitative MS [16]. A key feature of our approach was to use the SUMO
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isopeptidase Ulp1 to facilitate the identification and quantification of lower-abundance sumoy-
lated proteins. However, this approach prevented the identification of sumoylation sites, as
Ulp1 treatment generates an unmodified lysine that is indistinguishable from any other
unmodified lysine in the protein. As described here, we have adapted this approach to facilitate
the identification of the specific lysine on proteins to which SUMO is conjugated. To identify
the sites of SUMO conjugation, we first chemically acetylate unmodified lysines on sumoylated
proteins. The acetylated sumoylated proteins are then treated with Ulp1 to liberate SUMO,
thereby exposing an unmodified lysine at each sumoylation site that can be identified by MS.
Using this method we analyzed auto-sumoylation of the E1 enzyme and performed a prote-
ome-wide analysis of protein sumoylation sites in S. cerevisiae. We further characterized the
sumoylation of the E1 enzyme, Aos1 and Uba2, to validate this chemical labeling and Ulp1--
cleavage method.
Results
A chemical and enzymatic approach for sumoylation site analysis
Conventional MS-based methods to identify sumoylation sites rely on detection of a SUMO
remnant (EQIGG, in S. cerevisiae) linked to sumoylation sites as a signature (Fig 1A, trypsin is
used for illustration purpose). This Smt3 remnant will be fragmented by tandemMS, generat-
ing fragment ions that are unaccounted for during database search and thus compromise the
sequencing of sumoylated peptides. To overcome this difficulty, we developed a method
involving chemical acetylation of all unmodified lysines of SUMO and sumoylated proteins,
followed by cleavage with Ulp1 to remove SUMO and generate an unmodified lysine on the
targeted protein (Fig 1B). After this two-step treatment, each unmodified lysine specifically
marks a sumoylation site. After digestion by trypsin or other endopeptidases, unmodified
lysine in linear peptides can be readily identified by MS. Since trypsin specifically recognizes
positively charged lysine and arginine, but not uncharged acetylated lysine, we considered two
cases of detecting unmodified lysines in trypsin-treated preparations. In Case 1, owing to the
trypsin cleavage C-terminal to lysine and arginine residues, an unmodified lysine is detected as
the C-terminal amino acid of a peptide. In Case 2, since acetylated lysine is uncharged and
hence not recognized by trypsin, any lysine located immediately N-terminal to a detected tryp-
tic peptide is expected to be unmodified, and therefore a candidate sumoylation site.
To address whether Ulp1 could properly cleave SUMO after acetylation, we performed an
in vitro sumoylation reaction using SUMO E1 (Aos1-Uba2), E2 (Ubc9) and E3 (Mms21)
enzymes. Addition of ATP caused an accumulation of poly-SUMO chains, which migrate in a
smear-like pattern in an SDS-PAGE gel (Fig 1C, lane 2). In vitro sumoylation reaction products
were acetylated by treatment with acetic anhydride. Then, one half of the acetylated sample
was left untreated (Fig 1C, lane 3), while the other half was treated with Ulp1. We found that
treatment of the acetylated sample with Ulp1 resulted in disassembly of poly-SUMO chains
(Fig 1C, lane 4). Thus, acetylation of Smt3 did not affect the ability of Ulp1 to disassemble
poly-SUMO chains.
To use unmodified lysine as a faithful surrogate of sumoylation site mapping, it is necessary
to obtain a complete acetylation prior to Ulp1 treatment. To address this, we expressed 6xHIS-
3xFLAG-tagged SUMO (HF-SUMO) at the endogenous SMT3 locus in yeast cells and purified
sumoylated proteins as described previously [16]. The sumoylated proteins were treated with
Ulp1 to remove SUMO and eluted from the anti-FLAG resin (Fig 1D). The Ulp1-eluted pro-
teins were then acetylated using increasing concentrations of acetic anhydride, digested by
trypsin and analyzed by tandemMS. We then quantified the number of peptides that contained
either unmodified lysine or acetylated lysine. As shown in Fig 1E, in the absence of acetic
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anhydride treatment, virtually all the peptides identified of known SUMO targets contain
unmodified lysine (note: SUMO was removed prior to acetic anhydride treatment, Fig 1D).
Addition of acetic anhydride drastically reduced the amount of unmodified lysine concurrent
with accumulation of acetylated lysine. At concentrations above 25 mM acetic anhydride, very
few unmodified lysines were detected, indicating that acetylation had gone to near completion.
Additionally, as acetylation approaches completion, the number of total peptides identified
decreases (Fig 1E), which could be caused by the inability of trypsin to cleave acetylated lysine
within proteins. Because the sizes of peptides are expected to be larger, it is unclear whether
this decrease in number of peptides affects protein sequence coverage. We note here that alter-
native endopeptidases can be used to improve protein sequence coverage and this is made pos-
sible by the acetylation and Ulp1-cleavage method. Based on these results all subsequent
experiments were conducted using treatment with 50 mM acetic anhydride.
Fig 1. A new chemical and enzymatic approach to analyze protein sumoylation site. (A) Schematic of the conventional method using intact SUMO
remnant as a signature for MS analysis. (B) Schematic of our new method (see text for details). (C) In vitro sumoylation reaction was performed using purified
E1, E2 and Mms21 enzymes to generate poly-SUMO chains. After acetylation, treatment by Ulp1 disassembled poly-SUMO chains. (D) Method to evaluate
acetylation efficiency of known SUMO targets purified from yeast cells. Ulp1 was used prior to acetylation reaction. (E) Comparison of acetylated versus
unmodified lysine identified for known SUMO targets after treated by increasing concentration of acetic anhydride. The numbers of peptides containing
unmodified lysine and acetylated lysine (in parenthesis) are indicated.
doi:10.1371/journal.pone.0143810.g001
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Identification of sumoylation sites of SUMO E1 enzyme Aos1-Uba2
To identify sumoylation sites of E1 and E2 enzymes, we performed an in vitro sumoylation reac-
tion using purified Aos1-Uba2, Ubc9 and acetylated SUMO (Ac-SUMO). Acetylation of mono-
meric SUMO with acetic anhydride eliminated the formation of poly-SUMO chains during the
in vitro reaction. As shown in Fig 2A, multiple sumoylated species of Uba2 were observed, con-
sistent with sumoylation of multiple lysine on Uba2. Additional bands corresponding to
Fig 2. Multiple methods are used to identify sumoylation of E1 and E2 enzymes. (A) In vitro sumoylation using E1, E2 and acetylated SUMO, which
cannot form poly-SUMO chains, reveals higher molecular weight sumoylated species of Uba2, Aos1 and Ubc9. Ulp1 removal of SUMO allowed the
identification of unmodified lysine as sumoylation sites. (B) Peptides that led to the identification of sumoylation sites of E1 and E2 enzymes are listed.
Positions of the unmodified lysine (sumoylation site) are shown in parenthesis while all labeled lysine are acetylated. The periods flanking each peptide
indicate the site of trypsin cleavage. (C) Comparison betweenWT Smt3 and Smt3-I96R as substrate for in vitro sumoylation by Aos1-Uba2 and
Ubc9-K153R. Both WT Smt3 and Smt3-I96R are acetylated to prevent poly-SUMO formation. (D) Sumoylated peptides identified for Aos1 and Uba2 using
EQIGG and GG remnants with the position of lysine indicated in parenthesis. * The first methionine was removed from Aos1, which is fused with N-terminal
6xHIS tag for bacterial expression.
doi:10.1371/journal.pone.0143810.g002
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sumoylated Aos1 and Ubc9 were also observed. To identify the sumoylation sites of E1 and E2
enzymes, the in vitro reaction product was acetylated by the addition of acetic anhydride. Excess
glycine was then added to inactivate the remaining acetic anhydride and the sample was split
equally into two. In one half of the sample Ulp1 was added to cleave SUMO off and expose an
unmodified lysine for each sumoylation site, while the other half of the sample was not treated
with Ulp1. Both samples were treated with trypsin and analyzed by MS. As shown in Fig 2B and
S2 Table, no unmodified lysine was found for the E1 and E2 enzymes from the sample without
Ulp1 treatment, indicating that acetylation is complete. In contrast, several peptides of Aos1 and
Uba2 were identified in the Ulp1-treated sample, revealing unmodified lysine as candidate
sumoylation sites, including K153 of Ubc9 [13], K4 and K7 of Aos1, K229 and several other
lysine of Uba2.
The GG-remnant has been increasingly used for the identification of sumoylation sites,
which was first shown by the use of Smt3-I96R in yeast [45]. We sought to compare the use of
acetylated Smt3-I96R and WT Smt3 as substrates for in vitro sumoylation. For this purpose,
we used Ubc9-K153R, which cannot be inhibited by auto-sumoylation [13]. As shown in Fig
2C, both Smt3-I96R and WT Smt3 were readily attached to Uba2 and Aos1. We then digested
these reaction products by trypsin and identified sumoylation sites of E1 enzyme using the
expected SUMO remnant EQIGG and GG for WT Smt3 and Smt3-I96R, respectively. As sum-
marized in Fig 2D, the use of Smt3-I96R (GG-remnant) allowed for the identification of K4
and K7 of Aos1, K172, K229, K277 and K447 of Uba2, while the use of WT Smt3 (EQIGG-
remnant) only identified K7 of Aos1 and K277 of Uba2. Comparison between Fig 2B and 2C
shows that the GG-remnant and the Ulp1-cleavage methods are complementary, while the
EQIGG-remnant method performs noticeably worse.
The smt3-I96Rmutation does not cause adverse in vivo defects
Smt3-I96R can substitute for WT Smt3 for in vitro sumoylation and Smt3-I96R expressed
from a plasmid has been shown to rescue the loss of Smt3, which is essential for cell viability
[45]. However, the in vivo effect of smt3-I96Rmutation in yeast has not been fully character-
ized. To address this, we integrated the smt3-I96Rmutation in the endogenous locus of SMT3
and found that it causes no apparent growth defect in response to genotoxic agents (Fig 3A).
Considering protein sumoylation has recently been shown to have a major role in preventing
gross chromosomal rearrangements (GCRs) [16], we analyzed the effect of smt3-I96Rmutation
and found that the smt3-I96Rmutation does not cause appreciable change in the rate of GCRs
compared to the smt3-GGmutation, both yielding the mature form of SUMO in cells, although
SUMOmaturation mutation causes a modest increase in the rate of accumulating GCRs (Fig
3B). To further examine how Smt3-I96R is attached to intracellular proteins, we performed a
quantitative SUMO proteomic analysis to compare wild-type and smt3-I96R strain, using the
method described previously [16]. As shown in Fig 3C, most known sumoylated proteins show
less than two-fold differences in the relative abundance between WT and smt3-I96R strain,
indicating their sumoylation are not appreciably affected by the smt3-I96Rmutation. Collec-
tively, these results indicate that the smt3-I96Rmutation does not cause aberrant cell growth,
elevated DNA damage sensitivity and accumulation of GCRs, or appreciable changes to the
SUMO proteome in cells. These results support the use of HF-smt3-I96R strain for subsequent
biochemical studies.
Proteome-wide identification of sumoylation sites in S. cerevisiae
Next, we sought to identify sumoylation sites of proteins in S. cerevisiae using the method out-
lined in Fig 4A. To do so, we purified sumoylated proteins from theHF-smt3-I96R strain using
A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation
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first Ni-NTA and then anti-FLAG affinity resins [16]. Sumoylated proteins were eluted from
anti-FLAG affinity resins using denaturing buffer containing 6M Urea and the elution was
divided equally into three parts (Fig 4A). One-third of the sample was digested with trypsin to
generate peptides for MS analysis to identify peptides containing GG-remnants. The remaining
two-thirds of the sample was treated with acetic anhydride and then bound to Ni-NTA resins.
Fig 3. Characterization of the effect of smt3-I96Rmutation on cell growth, accumulation of GCRs and intracellular sumoylation. (A) Plate assay
showed that smt3-I96Rmutation does not cause any appreciable growth defect in the presence of genotoxic agents. Themec1Δmutant is used as a positive
control for its hypersensitivity to genotoxic agents including hydroxyurea (HU), camptothecin (CPT) and UV radiation. (B) Rates of accumulating GCRs in
smt3-I96Rmutant (strain HZY4247) and smt3GGmutant (strain HZY3392), both containing a C-terminal stop codon to expose the Gly-Gly repeat and thus
mature SUMO in cells. (C) Abundance ratios of the purified sumoylated proteins in WT (HZY2101) and smt3-I96R (HZY4248) strains, measured by
quantitative MS using the method described previously [16].
doi:10.1371/journal.pone.0143810.g003
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After washing, this sample was further divided equally into two with one treated with Ulp1 to
release proteins from SUMO, while the other sample was not treated with Ulp1. Both samples
were digested with trypsin and peptides from all three samples were processed for MS analysis
[48]. As summarized in Fig 4B, the GG-remnant method allowed identification of sixteen
sumoylation sites, eight of them were also found using the acetylation and Ulp1-cleavage
method, which identified many more sumoylation sites. Importantly, no sumoylation site was
found of any sumoylated protein in the sample without Ulp1 treatment, indicating that acetyla-
tion has gone to completion (see S3 Table for peptide list).
As summarized in Fig 4C, the GG-remnant method identified known sumoylation sites
including K127 and K164 of PCNA [28], K153 of Ubc9 [13], K426 of Shs1 and K63 of Cdc3
[27], which are underlined. In addition to identifying PCNA sumoylation sites, the acetylation
and Ulp1-cleavage method identified additional known sumoylation sites K11 and K30 of
Cdc3 and K437 of Shs1, but not K153 of Ubc9 and K426 of Shs1 [27]. Previous study has
shown that mutating these sumoylation sites of Cdc3 and Shs1 did not completely eliminate
their sumoylation in vivo [27], suggesting that additional sumoylation site(s) exist at a lower
Fig 4. Proteome-wide analysis of protein sumoylation sites using GG-remnant method and the chemical labeling and Ulp1-cleavage method. (A)
Sumoylated proteins were purified using Ni-NTA and anti-FLAG affinity resins, eluted by denaturing method and then divided for various treatments as
indicated. (B) Venn diagram shows the number of sumoylation sites identified by the GG-remnant method, acetylation without Ulp1 cleavage, and acetylation
with Ulp1-cleavage method. (C) Sumoylation sites identified with the position of lysine for each protein shown in parenthesis. Previously known sumoylation
sites are underlined.
doi:10.1371/journal.pone.0143810.g004
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stoichiometry. Further study of the new sumoylation sites identified for Cdc3 and Shs1 here
could be informative. Sumoylation of PCNA/Pol30 is among the best characterized with only
two sumoylation sites K127 and K164 known to date [28]. Importantly, no other lysine was
found for Pol30 by either GG-remnant or the acetylation and Ulp1-cleavage method as
expected. Using the acetylation and Ulp1-cleavage method, we identified K167, K168 and
K172 in the crossover loop of Uba2 (~ 40% sequence coverage), although K229 of Uba2 was
not found. The GG-remnant method also allowed the identification of K172 of Uba2 as its
sumoylation site. Due to the relatively lower sequence coverage of Aos1 (~ 10%) in this proteo-
mic experiment, we did not identify sumoylation of K4 or K7 of Aos1, likely due to the relative
lower abundance of sumoylated Aos1 in vivo. We note here that several other known sumoyla-
tion sites including K54 of Tec1, K1220 of Top2 and K25 of Gcn5 were not identified here
[29,49,50]. Moreover, sumoylation sites of most sumoylated proteins were not identified here,
likely due to their relatively lower abundance in unperturbed wild-type cells. Therefore, further
studies using specific environmental stimuli or mutations to increase the abundance of sumoy-
lated proteins are necessary for their identification.
Characterization of Aos1 confirms its sumoylation at K4 and K7
Next we chose to confirm the sumoylation sites of the E1 enzyme identified here in order to
provide further support for the MS findings and to explore its potential function. To confirm
sumoylation of K4 and K7 of Aos1, we purified the Aos1-K4R and Aos1-K4R,K7R proteins
from bacteria, which formed a heterodimeric complex with Uba2 during all the purification
steps. As shown in Fig 5A, the Aos1 K4R mutation reduced sumoylation of Aos1, and K4R and
K7R double mutation further reduced Aos1 sumoylation. Thus, K4 and K7 are its major
sumoylation sites in vitro. Sumoylation of Uba2 and Ubc9 was not appreciably affected by
these mutations, indicating that sumoylation of K4 and K7 of Aos1 is not required for the enzy-
matic activity of the E1 enzyme.
In our proteome-wide experiment, we did not identify K4 and K7 of Aos1 to be sumoylated due
to the low (~ 10%) sequence coverage of Aos1. To evaluate sumoylation of these residues of Aos1
in vivo, we generated a strain in which bothHF-SUMO and AOS1-3HA alleles were integrated in
their chromosomal loci, respectively [16]. Analysis of Aos1 in whole cell lysate did not reveal any
sumoylated species of Aos1, indicating that the stoichiometry of Aos1 sumoylation in vivo is very
low. Therefore, we chose to enrich Aos1-3HA using anti-HA affinity purification and then analyze
the purified sample by immunoblotting. As shown in Fig 5B, two sumoylated bands were found for
Aos1 (Fig 5B, lane 2). Ulp1 treatment eliminated both bands, confirming they contain sumoylated
Aos1. Interestingly, only the lower but not the upper sumoylated band of Aos1 was reduced by the
K4Rmutation and eliminated by the K4R and K7R double mutations. The upper sumoylated band
of Aos1 is consistent with the presence of multiple sumoylation sites or alternatively one sumoyla-
tion site of Aos1 together with an unknownmodification in vivo (Fig 5A). The latter possibility
could exclude its identification by the methods described here. We next examined the phenotype of
the aos1-K4R, K7R double mutant and found no apparent growth defect or elevated sensitivity to
genotoxic agents for this mutant (Fig 5C), indicating that auto-sumoylation of K4 and K7 of Aos1
is not essential for its function in vivo, although we cannot exclude a possible redundant function of
the unknown sumoylation site of Aos1. Taken together, these findings confirmed sumoylation of
K4 and K7 of Aos1 in vitro and in vivo, thus validating our method.
Multiple sumoylation in the crossover loop of Uba2 occurs in vivo
Among the sumoylation sites identified for Uba2 following in vitro sumoylation reaction (Fig
2), K229 conforms to the known consensus sumoylation motif [27]. The K229-containing
A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation
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peptide of Uba2 was identified via multiple methods (Fig 2), indicating that it is likely a major
sumoylation site of Uba2 in vitro. To test this, we purified recombinant Uba2-K229R, together
with WT Aos1, and tested its sumoylation in vitro. As shown in Fig 6A, sumoylation of Uba2 is
noticeably reduced, but not eliminated, by the uba2-K229Rmutation. The presence of addi-
tional sumoylated species of Uba2-K229R is consistent with the observation that Uba2 can be
sumoylated at multiple lysine in vitro (Fig 2).
Instead of analyzing the in vitro sumoylation sites of Uba2, which could be artificial, we
turned our attention to the sumoylation sites of Uba2 identified from our proteome-wide anal-
ysis. As shown in Fig 4 above, several lysines in the crossover loop of Uba2, including K167,
K168 and K172, were identified. The crossover loop lies in the active site of Uba2 and is near
the catalytic Cys-177 [10]. To examine a possible function for these sumoylation sites, we gen-
erated uba2-3KRmutant, in which K167, K168 and K172 in the crossover loop of Uba2 were
changed into arginine, respectively. We first examined the effect of uba2-K229R and uba2-3KR
mutations on sumoylation of Uba2 in cells. Unlike Aos1 (Fig 5), the abundance of sumoylated
Uba2 is sufficiently high and can be readily seen from whole cell lysate without the enrichment
of Uba2 (Fig 6B). The uba2-K229Rmutation has little effect on Uba2 sumoylation in vivo,
while the uba2-3KRmutation specifically eliminates the lower sumoylated specie of Uba2 in
Fig 5. Effect of K4R and K7Rmutation on Aos1 sumoylation and function. (A) Effect of K4R and K7Rmutations on sumoylation of Aos1 in vitro. (B)
Effect of Effect of K4R and K7Rmutations on Aos1 sumoylation in vivo. Epitope-tagged Aos1-HA in the HF-SUMO strain was purified using anti-HA affinity
resins and its sumoylated forms was detected using anti-FLAGWestern blot. (C) Growth and sensitivity of various sumoylation-defective aos1mutants to
genotoxic agents. 10-fold dilution of the same amounts of cells were plated and incubated at 30°C for 3 days. Themec1Δmutant is used as a positive control
for its hypersensitivity to genotoxic agents including hydroxyurea (HU), camptothecin (CPT) and UV.
doi:10.1371/journal.pone.0143810.g005
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vivo, confirming the three lysine residues (K167, K168 and K172) in the crossover loop of
Uba2 are its major auto-sumoylation sites in vivo. We next examined the growth phenotype of
these uba2mutants and found that the uba2-3KRmutant exhibits no obvious growth defects
or sensitivity to genotoxic agents (Fig 6C). The lack of growth defect for the uba2-3KRmutant
suggested that the essential function of Uba2 including its catalytic activity is unlikely affected.
Taken together, these results provide further support for the sumoylation sites of Uba2 identi-
fied and a validation of our new method.
Discussion
Protein sumoylation regulates essentially all major nuclear processes in eukaryotic cells and is
essential for cell viability. Hundreds of proteins have been found to be sumoylated [17,20–27];
however, relatively little is known about their specific sumoylation sites and the biological func-
tion of their sumoylation. Among them, the function of sumoylation of the SUMO E1, E2 and
E3 enzymes remains poorly understood except for Ubc9 [13–15]. A major barrier to under-
standing the functions of sumoylation of the sumoylation enzymes and their substrates has
been the lack of suitable methods to identify sumoylation sites. The GG-remnant method was
initially reported in yeast and it has later being adopted for mammalian studies [45–47]. Here
we report the development of a chemical labeling and Ulp1-cleavage method to identify
sumoylation sites, and compare this method with the standard GG-remnant method [45]. We
further examined sumoylation of the E1 enzyme Aos1 and Uba2 to validate our new method
and evaluate how these methods can be used for biological applications.
Fig 6. Characterization of Uba2 sumoylation. (A) Effect of uba2-K229Rmutations on the ability of Aos1-Uba2 in catalyzing sumoylation reaction. (B) Effect
of uba2-K229R and uba2-3KR on Uba2 sumoylation in vivo. Whole cell lysates from the indicated yeast strains were subjected to Western blot analysis. (C)
Effect of uba2-K229R and uba2-3KRmutations on cell growth. Themec1Δmutant is used as a positive control for sensitivity to hydroxyurea (HU),
camptothecin (CPT) and UV.
doi:10.1371/journal.pone.0143810.g006
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Conventional methods to identify sumoylation sites using MS are based on the detection of
a branched peptide containing an SUMO remnant, which limits the use of endopeptidases
with different sequence specificity. To overcome these problems, we combined the use of
chemical labeling and Ulp1 removal of SUMO to generate an unmodified lysine for each
sumoylation site, which is readily identified by MS (Fig 1). Acetylation treatment does cause
fewer tryptic peptides identified due to the loss of cleavable lysine for trypsin digestion (Fig
1E), although protein sequence coverage may be less affected since peptides are expected to be
longer. Nevertheless, removal of SUMO remnant should allow the use of alternative endopepti-
dases to improve protein sequence coverage if needed. One concern of our new method is that
incomplete acetylation would lead to false-positive identification of sumoylation sites. To
address this, we evaluated the use of a negative control without Ulp1-treatment, which should
yield no unmodified lysine assuming acetylation is complete. Results of this negative control
provided further support for the completion of the acetylation reaction and that the sumoyla-
tion sites identified using the Ulp1-cleavage method are likely to be correct (Figs 2B and 4B).
Considering that GG-remnant has been increasingly used to identify protein sumoylation
sites [45–47], we chose to compare our method with the GG-remnant method (Fig 2). The
same sumoylation sites of Aos1, i.e., K4 and K7, were identified using GG-remnant method
and our new method, while the EQIGG-remnant method performed noticeably worse. Muta-
tions of both K4 and K7 largely eliminate sumoylation of Aos1, confirming that they are the
major sumoylation sites of Aos1 in vitro. Compared to Aos1, sumoylation of Uba2 is more
complex as it undergoes extensive sumoylation in vitro but not in vivo (see Figs 2A and 6B),
suggesting that some of the in vitro sumoylation sites of Uba2 identified could be artificial.
While the GG-remnant method allows the identification of K172 in the crossover loop in Uba2
catalytic domain, our new method identified all three lysine in the crossover loop of Uba2, i.e.,
K167, K168 and K172, as its in vivo sumoylation sites (Fig 4B). Further independent validation
experiments support this finding, although mutations of these sumoylation sites in the cross-
over loop of Uba2 do not compromise its essential function in cells (Fig 6).
Several lessons can be gathered from this study concerning the application of sumoylation
site mapping methods for a biological study. First, the abundance of sumoylated proteins of
interest is critical in order to identify their sumoylation sites by MS regardless of the method
used. For example, sumoylation of Uba2 appears to be more abundant than that of Aos1 in
unperturbed wild-type cells (see Figs 5 and 6), allowing the identification of in vivo sumoyla-
tion sites of Uba2 but not Aos1 (Fig 4). Second, a combination of in vitro and in vivo studies
should be pursued to complement each other. For example, identification of K4 and K7 of
Aos1 as in vitro sumoylation sites prompted us to test and confirm their sumoylation in vivo,
despite that these sumoylation sites of Aos1 were not identified in our proteome-wide site-
mapping experiment (Fig 4). Interestingly, sumoylation of K229 of Uba2 was readily identified
from in vitro sumoylated Uba2, but not detected in the proteome-wide study. Consistent with
this observation, the K229R mutation of Uba2 has little effect on its sumoylation in vivo;
although we cannot exclude the possibility that sumoylation of K229 may occur at a relatively
lower stoichiometry in vivo. Despite these progresses, additional sumoylation of Aos1 and
Uba2 appear to exist. It is interesting to note that the sumoylation sites found for Uba2 in yeast
differ from those found for mammalian SAE2, the ortholog of Uba2 [18,19], raising the possi-
bility that some of these sumoylation sites may have different functions in yeast and human.
Third, the GG-remnant method and our new method are complementary and they both should
be used for specific applications if needed. It has been shown that anti-GG-remnant antibody
could be used to improve the identification of sumoylated peptides [46,47], which we did not
use for the study described in Fig 4. Moreover, alternative endopeptidases other than trypsin
could be used for the use of our chemical labeling and Ulp1-cleavage method to improve
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peptide sequence coverage and thus sumoylation site identification if needed. Considering the
differences of these methods, we believe they are complementary and should both be used in
future biological investigations. Finally, due to the relatively low abundance of most sumoy-
lated proteins in unperturbed wild type cells, their sumoylation sites remain to be identified in
our proteomic experiment (Fig 4). One way to overcome this limitation is to apply specific sti-
muli or mutations to elevate the abundance of specific sumoylated proteins during specific bio-
logical investigations regardless of the methods used for sumoylation site identification. In
summary, the findings presented here demonstrated that the chemical labeling and Ulp1-clea-
vage method provides a useful alternative to the standard GG-remnant method for sumoyla-
tion site studies.
Material and Methods
Yeast genetics method and strains used
Standard yeast genetic and molecular biology methods were used to generate mutations of
Aos1 and Uba2. All point mutations of AOS1 and UBA2 in yeast were integrated in their
respective chromosomal loci and verified by DNA sequencing. A list of yeast strains used in
this study is shown in S1 Table.
In vitro sumoylation reaction
For each sumoylation reaction, 0.4 μMAos1-Uba2 (E1), 2 μMUbc9 (E2), and 6 μM Smt3 or
acetylated Smt3 was used. 0.4 μMMms21 (E3) was added to the reactions indicated. These pro-
teins were purified using a combination of Ni-affinity, ion exchange and gel filtration columns
as previously described [51]. To initiate sumoylation reaction, a final concentration of 1 mM
ATP and 2 mMMgCl2 was added as indicated. Sumoylation reaction also contains 20mM
HEPES pH7.5, 0.15M NaCl and 0.1% NP-40 and it was performed at 30°C for 1 hour unless
noted otherwise.
Acetylation reaction and Ulp1 treatment
To each 100 μl of sumoylation reaction above, 75 mM sodium carbonate and 50 mM acetic anhy-
dride was added sequentially and incubated for 2 hours. To inactivate any residual acetic anhy-
dride, 100 μl of 1M Tris (pH 8.0) was added for 30 min. All of these steps were performed at room
temperature. 1 μg of recombinant Ulp1 was then added to cleave SUMO for 2 hours at 30°C.
Proteome-wide analysis of sumoylation sites using HF-smt3-I96R strain
4 liters ofHF-smt3-I96R cells were grown in YPD to an OD600nm of 1.0 and harvested to purify
sumoylated proteins using the method described previously with the following modifications
[16]. After the two-step Ni-NTA and anti-FLAG affinity purifications, sumoylated proteins were
eluted from anti-FLAG resins by incubating in a buffer containing 6M Urea, 75 mM sodium car-
bonate and 0.1% NP-40. One third of the eluted sample was diluted 5-fold by PBS buffer and
then digested with trypsin for MS analysis. Two-thirds of the eluted sample was incubated with
50 mM acetic anhydride for over 2 hours at room temperature. This sample was then incubated
with 100 μl Ni-NTA resins to capture sumoylated proteins. The Ni-NTA resins were then
washed with PBS buffer containing 0.2% NP-40 to remove Urea and then divided into two equal
portions. One sample was digested with trypsin without Ulp1 treatment, while the other sample
was incubated with 1 μg Ulp1 and then digested with trypsin. Following trypsin digestion, all
three samples were processed for MS analysis as described previously [48].
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MS data analysis method
The methods for analysis of the tandem mass spectra for peptide identification are the same as
those described previously except for the following [16,48]. To search GG-remnant, a variable
modification of 114.0429 Dalton on lysine was used. To search EQIGG-remnant, a variable
modification of (484.2282 Dalton) on lysine was used. To search for unmodified lysine due to
Ulp1-cleavage, we found that among 20 amino acids, tyrosine can also be modified by acetyla-
tion to a varying extent, thus variable modifications (42.01057 Dalton) of both tyrosine and
lysine by acetylation were used in database search. Additionally, a false discovery rate of 1%
was applied to the peptides identified, using a decoy protein database. The search results were
then filtered such that only known sumoylated proteins were kept for further analysis, and this
is because the same method was used to purify sumoylated proteins from essentially wild-type
cells under identical growth condition [16]. Since trypsin was used, we considered both cases
in which lysine is either at the C-terminal end of the peptide found or immediately precedes
the peptide identified, the latter is based on the known specificity of trypsin to cleave after
unmodified lysine and arginine. Finally, we manually inspected the tandemMS spectra for
those peptides containing candidate sumoylation sites. For manual inspection, we required
that peptides identified are tryptic at both ends with all major ions in the MS/MS spectrum
assigned as either Y-ion or B-ion series. The presence of proline should be accompanied by a
preferred fragmentation N-terminal to the proline. The assignment of sumoylated lysine is
usually unambiguous since it is the only available lysine of the peptide identified. In cases
where a tyrosine is present in a peptide, the existence of fragmentation ions that distinguish
between lysine and tyrosine was confirmed during manual inspection. Additionally, we have
deposited the MS data obtained in this study in a publically accessible database (http://massive.
ucsd.edu/ProteoSAFe/result.jsp?task=a0db6d0a63dd4bb6b1684334404e9e5e&view=
advanced_view).
Anti-HA immune-purification method
For Western blot analysis of purified Aos1, 50 ml culture of Aos1-3HA strain was grown in
YPD at 30°C to OD600 0.85. Cell pellet was lysed using glass beads method in 0.8 ml of 0.1 M
sodium hydroxide, 2% SDS. Whole cell lysate was then neutralized by 0.1 M hydrochloride
acid and then 0.1 M Tris pH8.0. The sample was reduced by 10 mM dithiothreitol and alkyl-
ated by 40mM iodoacetamide. For immunoprecipitation, 50 μL anti HA-agarose beads
(Sigma) was added and incubated for 2 hours at 30°C. Anti-HA beads were washed using
TBS-NP40, and the bound proteins were eluted after heated to 100°C in the presence of 1%
SDS. To detect Uba2-3xHA sumoylation, which is sufficiently abundant, whole cell lysate was
used directly for anti-HAWestern blot analysis.
Phenotype analysis
For plate assay, 10-fold serial dilution of various yeast strains were plated on the indicated
plates and grown for up to 3 days at 30°C before pictures are taken. The method used for GCR
analysis was described previously [52].
Supporting Information
S1 Table. List of yeast strains used in this study.
(PDF)
A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation
PLOS ONE | DOI:10.1371/journal.pone.0143810 December 3, 2015 14 / 17
S2 Table. List of peptides identified fromMS analysis of in vitro sumoylation reaction with
or without Ulp1 treatment after acetylation (see Fig 2B).
(XLS)
S3 Table. List of peptides identified from proteome-wide analysis ofHF-smt3-I96R strain
(see Fig 4).
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